Degradation of serum amyloid A in amyloid-susceptible and amyloid-resistant mouse strains

Scandinavian Journal of Immunology

Volumn 44, Issue 3, 1996, Pages 223-228

  Elliott Bryant, R ^a,b   Liang, J S ^b   Sipe, J D ^b   Cathcart, E S ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; HIGH DENSITY LIPOPROTEIN; PHENYLMETHANYLSULFONYLFLUORIDE; SERINE PROTEINASE; SERUM AMYLOID A; UNCLASSIFIED DRUG;

AMYLOIDOSIS; ANIMAL CELL; ARTICLE; FEMALE; GENETIC LINKAGE; MALE; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL;

EID: 0029762733     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-301.x     Document Type: Article

References (45)

1. Hoffman JS, Benditt EP. Changes in high density lipoprotein content following endotoxin administration in the mouse: formation of serum amyloid rotein-rich subfractions. J Biol Chem 1982;257:10510-17.
2. de Beer MC, Kindy MS, Lane WS, de Beer FC. Mouse serum amyloid A protein (SAA5): structure and expression. J Biol Chem 1994;269:4661-7.
3. McAdam KPWJ, Sipe JD. Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J Exp Med 1976;144:1121-7.
4. Badolata RJ, Wang M, Murphy WJ et al. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 1994;180:203-9.
5. Xie LR, Badolato R, Murphy WJ et al. A novel biological function of serum amyloid AA. Induction of T lymphocyte migration and adhesion. J Immunol 1995;155:1184-9.
6. Liang J-S, Sipe JD. Recombinant human serum amyloid A (apoSAAp) bind cholesterol and modulates cholesterol flux. J Lipid Res 1995;36:37-46.
7. Husebekk A, Skogen B, Husby G, Marhaug G. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol 1985;21:283-7.
8. Ericsson N, Eriksen LH, Pearsall N, Lagunoff D, Benditt EP. Mouse amyloid protein AA: homology with non-immunoglobulin protein of human and monkey amyloid substance. Proc Natl Acad Sci USA 1976;73:964-7.
9. Dwulet FE, Benson MD. Primary structure of amyloid fibril protein AA in azocasein-induced amyloidosis of CBA /J mice. J Lab Clin Med 1987;110:322-9.
10. Araki S, Ikegawa S. Transthyretin and apo-Al amyloidosis, In: Kisilevesky R, Benson MD, Frangione B, Gauldie J, Muckle TJ, Young ID, eds. Amyloid and Amyloidosis 1993. New Jersey: Parthenon Publishing, 1994;422-7.
11. GorevicPD, MunozPC, Casey TT et al. Polymerization of intact beta-2 microglobulin in tissue causes amyloidosis in patients on chronic dialysis. Proc Nat Acad Sci USA 1986;83:7908-12.
12. Ericsson LH, Eriksen M, Walsh KA, Benditt EP. Primary-structure of duck amyloid protein A: the form deposited in tissues may be identical to its serum precursor. FEBS 1987;218:11-16.
13. Kisilevsky R, Narindrasorasak S, Tape C, Tan R. Boudreau L. During AA amyloidogenesis is proteolytic attack on serum amyloid A a pre- or post-fibrillogenic event? Amyloid 1994;1:174-83.
14. Lavie G, Zucker-Franklin D, Franklin EC. Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes. J Exp Med 1978;148:1020-31.
15. Skogen B, Natvig JB, Borresen AL, Berg K. Degradation of amyloid-related serum protein SAA by a component present in rabbit and human serum. Scand J Immunol 1980;11:643-8.
16. Silverman SL, Cathcart ES, Skinner M, Cohen AS. The degradation of serum amyloid A protein by activated polymorphonuclear leucocytes: participation of granulocytic elastase. Immunol 1982;46:737-44.
17. Yamada T, Liepnieks JJ, Kleuve-Beckerman B, Benson MD. Cathepsin B generates the most common form of amyloid A (76 residues) as a degradation product from serum amyloid A. Scand J Immunol 1994;41:94-7.
18. Baba S, Miura K, Shirasawa H. In vitro assembly of murine amyloid human transthyretin to form amyloid-like fibrils. In: Natvig JB, Fdrre O, Husby G et al. eds. Amyloid and Amyloidosis. Dordecht: Kluwer Academic Publishers. 1991:497-500.
19. Yamada T, Kluve-Beckerman B. Liepnieks JJ, Benson MD. Fibril formation from recombinant serum amyloid A. Biochim Biophys Acta 1994;1226:323-9.
20. Westermark GT, Engstrom U, Westermark P. The N-terminal segment of protein AA determines its fibrillogenic property. Biochem Biophys Res Comm 1992;182:27-33.
21. Shirahama T, Cohen AS. Intralysosomal formation of amyloid fibrils. Am J Pathol 1975;81:101-6.
22. Takahashi M, Yokota T. Kawano H. Gondo T. Ishihara T. Uchino F. Ultrastructual evidence for intracellular formation of amyloid fibrils in macrophages. Virchows årch ål989;415:411-19.
23. Taylor BA, Rowe L. Genes for serum amyloid A map to chromosome 7 in the mouse. Mol Genet 1984;195:491-9.
24. Yamamoto K-I. Shiroo M, Migita S. Diverse gene expression for isotypes of murine serum amyloid A protein during acute phase reaction. Science 1986;232:227-9.
25. Stearman RS, Lowell CA, Pelzman CG. Morrow JF. The sequence and structure of a new serum amyloid A gene. Nucleic Acid Res 1986;14:797-812.
26. 2-terminal sequence identity with only one of two serum amyloid protein (apoSAA) end products. J Exp Med 1984;159:641-6.
27. Meek RL, Hoffman JS, Benditt EP. Amyloidogenesis: one serum amyloid A isotype is selectively removed from the circulation. J ExpMed 1986;163:499-510.
28. Shiroo M, Kawahara E, Nakanishi I, Migita S. Specific deposition of serum amyloid A protein 2 in the mouse. Scand J Immunol 1987;26:709-16.
29. de Beer MC, de Beer FC, Beach CM, Carreras I, Sipe JD. Mouse serum amyloid protein: complete amino acid sequence and mRNA analysis of a new isoform. Biochem J 1992;283:673-8.
30. Sipe JD, Carreras I, Gonnerman WA, Cathcart ES, de Beer MC, de Beer FC. Characterisation of the inbred CE/J mouse strain as amyloid resistant. Am J Pathol 1993;143:1480-5.
31. de Beer MC, de Beer FC. McCubbin WD, Kay CM, Kindy MS. Structural prerequisites for serum amyloid A fibril formation. J Biol Chem 1993;268:20606-12.
32. Cathcart ES, Sipe JD, Gonnerman WA, Carreras I, de Beer MC, de Beer FC. Amyloid resistance in the CE/J mouse. In: Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle TJ, Young ID, eds. Amyloid and Amyloidosis 1993. New York: Parthenon Publishing, 1994:29-31.
33. Coetzee GA, Strachen AF, van der Westhuyzen DR, Hoppe HC, Jeenah MS, de Beer FC. Serum amyloid A-containing high density lipoprotein 3: density, size and lipoprotein composition. J Biol Chem 1986;261:9644-50.
34. Lowry OH, Rosebrough NJ. Farr AI, Randall RJ. Protein measurement with the Folin Wu phenol reagent. J Biol Chem 1951;193:265-75.
35. Sipe JD, Gonnerman WA, Loose LD, Knapschaefer G, Xie W-J, Franzblau C. Direct binding solid phase ELISA for serum amyloid A (SAA). J Immunol Meth 1993;125:125-35.
36. Fuks A. Zucker-Franklin D. Impaired Kupffer cell function precedes development of secondary amyloidosis. J Exp Med 1985;161:1013-28.
37. 2-terminal sequence identity with only one of two serum amyloid protein (apoSAA) gene products. J. Exp Med 1984;159:641-6.
38. Gonnerman WA, Elliott-Bryant RE, Carreras I, Sipe JD, Cathcart ES. Linkage of protection against amyloid fibril formation in the mouse to a single autosomal dominant gene. J Exp Med 1995;181:2249-52.
39. Bausserman LL, Saretelli AL, van Zuiden P, Gollagher CJ, Herbert PN. Degradation of serum amyloid A by isolated perfused rat liver. J. Biol Chem 1987;262:1583-9.
40. Tape C, Kisilevsky R. Apolipoprotein A-1 and apolipoprotein SAA half-lives during acute inflammation and amyloidogenesis. Biochem Biophys Acta 1990;1043:295-300.
41. Bausserman LL, Herbert PN, Rodger R, Nicolisi RJ. Rapid clearance of serum amyloid A from high-density lipoproteins. Biochem Biophys Acta 1984;792:186-91.
42. Polacek D, Byrne RE, Fless GM, Scanu AM. In vitro proteolysis of human plasma low density lipoproteins by an elastase released from human blood polymorphonuclear cells. J Biol Chem 1986;261:2057-63.
43. Wohlgethan JR, Cathcart ES. Amyloid resistance in A/J mice is determined by a single gene. Nature (Lond) 1979;278:453.
44. Wohlgethan JR, Cathcart ES: Amyloid resistance in A/J mice: studies with a transfer model. Lab Invest 1980;42:663-7.
45. Butler A, Whitehead AS. Resistance to secondary amyloidosis in A/J mice is not significantly associated with allelic variants linked to the serum amyloid A gene cluster. Scand J Immunol 1994;40:355-8.